S-nitrosoglutathione acts as a small molecule modulator of human fibrin clot architecture.
BACKGROUND
Altered fibrin clot architecture is increasingly associated with cardiovascular diseases; yet, little is known about how fibrin networks are affected by small molecules that alter fibrinogen structure. Based on previous evidence that S-nitrosoglutathione (GSNO) alters fibrinogen secondary structure and fibrin polymerization kinetics, we hypothesized that GSNO would alter fibrin microstructure.


RESULTS
Accordingly, we treated human platelet-poor plasma with GSNO (0.01-3.75 mM) and imaged thrombin induced fibrin networks using multiphoton microscopy. Using custom designed computer software, we analyzed fibrin microstructure for changes in structural features including fiber density, diameter, branch point density, crossing fibers and void area. We report for the first time that GSNO dose-dependently decreased fibrin density until complete network inhibition was achieved. At low dose GSNO, fiber diameter increased 25%, maintaining clot void volume at approximately 70%. However, at high dose GSNO, abnormal irregularly shaped fibrin clusters with high fluorescence intensity cores were detected and clot void volume increased dramatically. Notwithstanding fibrin clusters, the clot remained stable, as fiber branching was insensitive to GSNO and there was no evidence of fiber motion within the network. Moreover, at the highest GSNO dose tested, we observed for the first time, that GSNO induced formation of fibrin agglomerates.


CONCLUSIONS
Taken together, low dose GSNO modulated fibrin microstructure generating coarse fibrin networks with thicker fibers; however, higher doses of GSNO induced abnormal fibrin structures and fibrin agglomerates. Since GSNO maintained clot void volume, while altering fiber diameter it suggests that GSNO may modulate the remodeling or inhibition of fibrin networks over an optimal concentration range.
Department of Biochemistry, School of Medicine, Keio University, Tokyo, Japan. rbateman@z6.keio.jp
Ryon M
RM
Bateman
Christopher G
CG
Ellis
Makoto
M
Suematsu
Keith R
KR
Walley
D005337:Fibrin / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism*; D005340:Fibrinogen / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D010949:Plasma / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D026422:S-Nitrosoglutathione / Q000494:pharmacology*
D026422:S-Nitrosoglutathione; D005337:Fibrin; D005340:Fibrinogen